Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

HD17 for Intermediate Stage Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01356680
Recruitment Status : Active, not recruiting
First Posted : May 19, 2011
Last Update Posted : July 22, 2019
Information provided by (Responsible Party):
Prof. Dr. Andreas Engert, University of Cologne

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2021